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tension or re-establishment of tissue pre-
tension is believed to be mainly caused by 
fibroblasts and myo-fibroblasts, starting 
already with the traction forces they 
impose when migrating into the trauma 
region.[3,4] As part of the healing process, a 
fibrous network rich in collagen-I is estab-
lished in the injured region that mechani-
cally stabilizes the tissue and shields 
cells and transitory extracellular matrix 
components from excessive mechanical 
stress.[5–9] So far, tissue contraction and 
collagen deposition have been regarded 
as simultaneous, but not as dependent 
processes in healing. While tissue con-
traction is attributed to cell traction forces 
with experimental support from in vitro 
studies, collagen fibrils are regarded to 
provide load bearing and stress-shielding 
functions subsequent to initial tissue 
contraction.[10–12] However, first indica-
tions for a gradual conversion of cellular tension to the extracel-
lular matrix (ECM) provoke a closer look at a direct involvement 
of collagen fibrils in tissue tensioning.[3,13]
The complete restoration of tissue functionality after injury 
is, to a large degree, controlled by the re-establishment of the 
ECM. Connected to their functionality, almost all tissues exhibit 
a basal level of inherent tension often referred to as “resting 
tension.”[3] Consequently, to achieve tissue regeneration after 
injury, the wound is not only required to close, but tissue 
architecture and intrinsic tension need to be re-established, 
usually from a soft and unstructured coagulated blood clot. 
Fibronectin fibers that play an important role in the early phase 
of healing were shown to be tensioned by cellular forces with 
consequences for the deposition of collagen fibrils.[8] However, 
the role of tensioned fibronectin fibers in wound contraction 
and tissue tensioning is unclear. Furthermore, function-related 
tension of collagen fibrils in bone was shown to be controlled 
by the interaction with water.[14,15] This specific mechanism of 
developing tension seems to be rather limited to mineralized 
tissue while detailed insights into the establishment of tension 
in early stages of bone regeneration and within tissues such as 
skin, nerves, vessels and ligaments are still missing.
Improper assembly and architectural arrangement of col-
lagen fibrils is associated with pathological conditions. Excessive 
cellular contraction, e.g., due to chronic myo-fibroblast activity, 
is found during hypertrophic scarring in a variety of tissues and 
organs and is linked to an increased deposition of collagen I.[4,16] 
Tissue stiffening compromises cellular functionality which 
Wound contraction is an ancient survival mechanism of vertebrates 
that results from tensile forces supporting wound closure. So far, tissue 
tension was attributed to cellular forces produced by tissue-resident (myo-)
fibroblasts alone. However, difficulties in explaining pathological deviations 
from a successful healing path motivate the exploration of additional 
modulatory factors. Here, it is shown in a biomaterial-based in vitro wound 
healing model that the storage of tensile forces in the extracellular matrix 
has a significant, so-far neglected contribution to macroscopic tissue 
tension. In situ monitoring of tissue forces together with second harmonic 
imaging reveal that the appearance of collagen fibrils correlates with tissue 
contraction, indicating a mechanical contribution of tensioned collagen 
fibrils in the contraction process. As the re-establishment of tissue tension 
is key to successful wound healing, the findings are expected to advance 
the understanding of tissue healing but also underlying principles of 
misregulation and impaired functionality in scars and tissue contractures.
Tissue Regeneration
1. Introduction
The contraction of tissue wounds is regarded as a life-saving 
mechanism and an essential process during tissue healing, e.g., 
in skin and many other tissues.[1,2] The generation of tissue 
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eventually results in tissue or organ failure.[17] Also, tissue 
stiffening in primary breast carcinomas was linked to aberrant 
collagen deposition and structure.[18] Insights into a potential 
contribution of fibrillar collagen to tissue contraction and ten-
sioning are lacking despite their value for the identification of 
strategies for tissue regeneration, but also for preventing tissue 
fibrosis or malignancy.
In this study, we used a biomaterial-based in vitro approach 
together with second-harmonic imaging to study the role of col-
lagen fibrils in tissue contraction. We found indications for a 
transfer of cell tensional forces into tensioned collagen fibrils 
that contributes to tissue tensioning and resulting contraction. 
Varying the biomaterial stiffness revealed that soft environ-
ments (1–3 kPa) could be contracted in absence of collagen 
fibrils (ascorbic acid depletion), while the contraction of stiffer 
environments was observed only in the presence of collagen 
fibrils. Together our data suggests a mechanical contribution of 
collagen fibrils in macroscopic tissue tensioning during tissue 
maturation beyond the hematoma phase. These insights might 
open new routes toward successful tissue regeneration but 
might also motivate to re-consider the mechanical role of the 
extracellular matrix in the development of tissue pathologies.
2. Results and Discussion
2.1. Synthetic Biomaterial Niche as Model for Wound Healing
In vitro systems used to study and quantify tissue contraction 
are mostly based on the incorporation of cells into collagen 
gels.[11,19–23] Even though deflecting microposts can be used to 
measure the development of tension in such gels, dissecting 
the individual contributions of cells and ECM is not trivial due 
to the gels’ complex poroelastic mechanical behavior.[10] Addi-
tionally, available information is limited to short time periods of 
usually 1–3 d where the deposition of fibrillar collagen cannot 
be expected.[10,20] Furthermore, the visualization of fibrillar 
collagen deposition, e.g., via second harmonic imaging (SHI), is 
difficult as signals from collagen gel and cell-secreted collagen 
fibrils are indistinguishable. Further, hydroxyapatite (HA), poly-
ethylene glycol (PEG) or polydimethylsiloxane-based (PDMS) 
biomaterials have been used to study in vitro tissue formation 
in voids but with limited possibilities to quantify macroscopic 
tensioning and contraction.[13,24–27]
In this study we used macroporous scaffolds fabricated 
from porcine collagen by a directional freezing and freeze-
drying process (1.5 wt/wt% collagen content, Matricel GmbH, 
Herzogenrath, Germany) as cell carriers.[28] The scaffolds 
featured an anisotropic architecture with channel-like pores 
along the cylinder axis (axial direction) and an isotropic pore 
pattern perpendicular to the direction of the channels (radial 
direction) (Figure 1a). We quantified a mean wall spanning 
distance of D = 101 ± 30 µm (mean ± S.D.) and a wall thick-
ness of T = 2.3 ± 0.9 µm. Mono-axial compression testing 
was used to characterize the scaffold’s mechanical stiffness 
revealing a significant difference between axial compression 
along (Eaxial = 4.1 ± 0.4 kPa) and radial compression perpendic-
ular (Eradial = 1.1 ± 0.5 kPa) to the pore orientation (Figure 1b). 
Most importantly, the material featured a spring-like, elastic 
deformation behavior with full restoration of the initial dimen-
sions and stiffness after multiple repetitive loading cycles 
(Figure 1c and Figure S1a,b, Supporting Information). Together, 
the soft, elastic and open-porous environment and the good 
spatial discrimination between the biomaterial and cell-secreted 
ECM was essential for the in situ measurement of tissue tension 
and to study the mechanical role of the ECM in this process.
Cylindrical scaffolds (5 mm Ø, 3 mm height) were seeded 
with primary human dermal fibroblasts (hdFs), as they rep-
resent the most relevant cell type to study wound contraction 
and tissue formation. The dip-in seeding procedure led to a 
homogeneous cell distribution and a uniform tissue formation 
process throughout the scaffold (Figure S1c,d, Supporting 
Information). An increasing alignment of hdFs and early 
deposited fibronectin fibers along the direction of the scaffold 
pores was found at 3, 7, and 14 d of culture (Figure 1d,e). Wall-
connecting struts that are part of the scaffold architecture were 
used by cells for the initial centripetal pore filling (day 3) but 
were of diminishing importance for cell and ECM organization 
when a dense and highly aligned cell network formed within 
the scaffold pores (7 and 14 d).
Aside of depositing fibronectin and other early ECM com-
ponents, fibroblasts express and secrete significant amounts of 
collagen.[29] As particularly fibrillar collagen exhibits a mechan-
ical load bearing and stress shielding function with potential 
relevance for tissue tensioning, we visualized collagen fibrils 
by second harmonic imaging (SHI) (Figure 1d, lower panel). 
Only individual collagen fibrils were identified after 3 d of cul-
ture but over time, a dense network of fibrillar collagen formed 
that followed the structural alignment of cells and fibronectin 
fibers along the scaffold pores (Figure 1e–g). Collagen fibrils 
were spanning over long distances throughout the sample, 
again with little structural distortion by wall-connecting struts 
(Figure 1d, yellow arrows). The limited contact to the scaffold 
material and the long-range organization indicated that the 
tissue formed inside the scaffold pores collectively organized 
on a macroscopic scale. Such a long-range organization of cells 
and ECM was observed previously in vitro and in vivo.[11,30]
Taken together, we observed a time-dependent cellular self-
organization and a consecutive deposition of fibronectin and 
fibrillar collagen within the channel-like scaffold pores resulting 
in a dense, highly aligned ECM network with almost identical 
structural properties as the cell-network. The unidirectional 
character of the cell-ECM network was advantageous for the sub-
sequent analysis of tissue tension as the mechanical interplay of 
cell/ECM tension acting against scaffold wall compression was 
mostly reduced to one spatial dimension—the direction of the 
scaffold pores. The uniform thickness of the parallel scaffold walls 
and their elastic deformation provided a spring-like substrate with 
very homogeneous stiffness in the direction of the pores (=axial 
direction). This was a prerequisite for the subsequent calculation 
of tissue tensional force based on scaffold strain.
2.2. In Vitro Tissue Contraction Depends on the Presence  
of Collagen Fibrils
It was reported before that cell traction forces are able to 
induce a macroscopic deformation of biomaterial scaffolds in 
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vitro.[11,19,22,31,32] In agreement with this, we observed a time-
dependent scaffold contraction, both in axial and radial direc-
tion, under supplementation of ascorbic acid that is required 
for collagen fibrillogenesis (Figure 2a). Scaffold contraction was 
still weak at day 3 but showed a pronounced increase until day 
14. At the same time radial contraction was significantly higher 
compared to axial contraction (Figure 2b,c). As this observation 
was contradictory to the high cell and ECM alignment along 
the scaffold pores we assessed the biomaterial deformation in a 
mechanically quantitative manner by calculating scaffold strain 
energies taking into account the higher compressive stiffness 
of the scaffold in axial compared to the radial direction. Con-
sequently, and in agreement with cell and ECM orientation, 
we found significantly higher strain energies in the axial com-
pared to the radial direction after 14 d of culture (Figure 2d). 
To exclude potential changes of the biomaterial’s macroscopic 
stiffness due to creep, we gradually compressed empty scaffolds 
using a mechano-bioreactor system described before mim-
icking the situation during culture of cell-seeded scaffolds.[33] 
No alterations of scaffold stiffness were found when reaching 
13% compressive strain representing the mean strain in axial 
direction exerted by cells over 14 d (Figure S2a, Supporting 
Information).
Assuming that cells initiate contraction of the environment 
by the application of traction forces alone, scaffold contraction 
would occur even in the absence of collagen fibrils. To test this, 
the formation of fibrillar collagen inside scaffold pores was 
suppressed by the depletion of ascorbic acid from the culture 
medium. While cell adhesion, proliferation and deposition of 
fibronectin fibers remained unaffected, a significant reduction 
in collagen density and pore filling was observed (Figure 2e, 
Figure S2b–d, Supporting Information). Most strikingly, samples 
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Figure 1. A structured collagen scaffold directs cell organization and ECM formation. a) Visualization of the highly organized cylindrical shaped scaf-
fold (5 mm Ø) (top left). Pictographic representation indicating radial (red) and axial (blue) direction of view (bottom left). Center and right panels 
show SEM images of pore architecture in radial (red dot) and axial direction (blue dot) including structural analysis of pore diameter (lower left) and 
wall thickness (lower right). Scale bar 250 µm. b) Compressive stiffness E of collagen scaffolds measured perpendicular (radial) or in the direction 
(axial) of the pores (mean ± S.D., n = 4). c) Compressive stiffness plotted over compression cycles (n = 4). Black lines indicate the mean with blue/
red belt as standard deviation. d) Confocal images of collagen scaffolds imaged in axial direction after 3, 7, or 14 d of culture. Samples were stained 
for fibronectin (green), actin (red), or cell nuclei (blue). Fibrillar collagen was visualized by SHI (lower panel). Yellow arrows indicate little influence 
of struts on structural alignment of collagen fibrils at later stages of culture. Scale bar 100 µm. e) Circular plots indicating the orientation distribution 
of actin (red), fibronectin (green), and collagen fibrils (grey) after 3,7, or 14 d of culture relative to the local pore orientation. The means are reflected 
as dark lines with standard deviation as colored belt (n = 2–4). f) Quantification of collagen signal density (a.u., arbitrary units) inside scaffold pores 
(mean ± S.D., n = 4–9). g) Quantification of the local anisotropy of fibrillar collagen signal inside scaffold pores (mean ± S.D., n = 4). Significance 
levels were calculated using the Mann–Whitney U test (two-sided) with the Bonferroni correction for comparison of multiple groups. Significance levels 
indicate # p < 0.1, * p < 0.05.
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cultured in the absence of ascorbic acid completely lacked macro-
scopic scaffold contraction over the 14 d of culture (Figure 2f,g). 
This was also reflected by significantly reduced values of total 
scaffold strain energy (radial + axial contributions) in the ascorbic 
acid-depleted groups for all analyzed time points (Figure 2h).
Together these findings provide evidence that collagen fibrils 
are essential elements in pore filling and tissue tensioning. The 
fact that measurable scaffold compression (straining) is taking 
place only when collagen fibrils are present was a first hint 
toward their central role for creating intrinsic tissue tension.
2.3. Indications for a Transfer of Cell Tensional Forces into  
the Fibrillar Collagen Network
Assuming that cellular forces can be added up linearly due to 
the high cellular alignment along the pores, the maximal force 
would be the sum of all parallel-acting individual cell forces. 
Consequently, macroscopic contraction would correlate with 
the contractile capacity of single cells.
Speculating that primary fibroblasts from different donors 
vary in their ability to generate traction forces, we expected 
additional insights into the dependency between cell tension 
and tissue tension from an interdonor comparison. We isolated 
primary dermal fibroblasts from seven different human donors 
(age 24.9 ± 6.9 years, mean ± S.D.) and performed single cell 
force measurements by traction force microscopy (TFM) 
(Figure 3a).[34,35] Surprisingly, aside of a strong intrinsic varia-
tion for each individual donor, we detected only small differ-
ences between donors with mean values ranging from 0.44 
(donor D6) to 0.76 pJ per cell (donor D1) (Figure 3b, Figure S3a, 
Supporting Information).
We next cultured fibroblasts from all seven donors individu-
ally inside collagen scaffolds and quantified scaffold contrac-
tion after 14 d of culture (Figure 3c). Remarkably, we observed 
a pronounced, up to 17-fold variation in the magnitude of 
scaffold contraction which did not correlate with differences 
in single cell forces (Figure S3b, compare donors D1 and D3, 
Supporting Information). As the depletion of ascorbic acid 
and the resulting lack of collagen fibrillogenesis had shown to 
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Figure 2. Macroscopic contraction depends on the deposition of a fibrillar collagen ECM. a) SHI of microtissues after 14 d of culture including ascorbic 
acid supplementation. Yellow arrowheads indicate cell-produced collagen fibrils. Scale bar 100 µm. b) Representative scans of seeded scaffolds for 
axial (blue dots) and radial (red dots) directions after seeding (day 0) and day 14 of culture with ascorbic acid supplementation. Scale bar 2 mm. 
c) Quantification of scaffold contraction in axial and radial directions expressed as percent of initial volume (day 0) for 3, 7, and 14 d of culture with 
ascorbic acid supplementation (n = 13–24). d) Calculated strain energy levels of the collagen scaffold as a result of macroscopic contraction both for 
radial (red) and axial (blue) direction (n = 7–19). e) SHI of microtissues after 14 d of culture without ascorbic acid supplementation. Scale bar 100 µm. 
f) Representative scans of seeded scaffolds for axial (red dots) and radial (blue dots) directions after seeding (day 0) and day 14 of culture without 
ascorbic acid supplementation. Scale bar 2 mm. g) Quantification of scaffold contraction in axial and radial directions expressed as percent of initial 
volume (day 0) for 3, 7, and 14 d of culture without ascorbic acid supplementation (n = 8). h) Calculated strain energy levels (total sample) as a result 
of macroscopic contraction cultured either in the presence or absence of ascorbic acid (n = 8–14). Significance levels via the Mann–Whitney U test 
(two-sided) and significance levels are indicated by symbols: * p < 0.05, ** p < 0.01, *** p < 0.001.
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abolish scaffold contraction, we hypothesized that a variation 
in the amount of collagen fibrils might be responsible for the 
observed differences in contraction. Indeed, fibrillar collagen 
density inside the scaffold pores showed an almost identical 
variation between the donors as it was observed for scaffold 
contraction (Figure 3d). Correlating collagen density and scaf-
fold contraction revealed a direct linear dependency (Figure S3c 
in the Supporting Information, r2 = 0.85).
In order to estimate the mechanical contribution of an indi-
vidual cell to the macroscopic scaffold contraction, we calcu-
lated scaffold strain energy based on the biomaterial mechanical 
properties and normalized this to the total number of cells 
(Figure 3f). While the obtained values do not reflect actual 
in situ 3D single cell forces (neglecting compression of cell-
secreted ECM components) or 2D cell forces quantified by TFM 
(not mimicking the physiological cell morphology and environ-
ment), they allow an estimation of the contribution of each cell 
to the macroscopic contraction. We further calculated a ratio of 
macroscopic scaffold strain energy and microscopic single cell 
strain energy (based on TFM data) which we termed force ampli-
fication factor AF (Figure 3g). Intriguingly, we observed that the 
two donors that exhibited the lowest mean values (AF = 0.5 for 
D1 and 0.6 for D2) of force amplification also showed a com-
plete lack of fibrillar collagen (Figure 3d,e). All other donors 
with visible collagen fibrils showed mean values ranging 
between AF = 6 (D4) and AF = 46 (D3). This indicated that 
fibrillar collagen strongly contributes to the generation of intra-
tissue tension. The linear correlation between the amplification 
factor AF and collagen fibril density further suggested that cells 
incrementally transfer tensional forces into the fibrillar collagen 
network (Figure 3h). In order to exclude a potential deroga-
tion of the results through a potential divergence of single cell 
forces during 3D culture, we characterized fibroblasts activated 
by 10 ng mL−1 TGF-β1 (Figure S3d,e, Supporting Information). 
We observed that resulting αSMA-positive fibroblasts featured 
a rather mild, approximately twofold increase of traction force 
compared to unstimulated controls in agreement with previ-
ously published data.[36] Finally, supplementation with ascorbic 
acid did not alter cell traction forces excluding systematic devia-
tions between the groups investigated.
Taken together, the data indicated that the ability to generate 
tissue tension and contraction not necessarily depends on the 
ability to generate high cellular traction forces but rather on 
the capability to transfer the generated forces into a network of 
pretensioned collagen fibrils.
2.4. Relevance of Collagen Fibril-Associated Tension during 
Wound Healing
In an injury situation, the repair-process including tissue con-
traction usually starts from a blood clot that forms directly after 
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Figure 3. Fibrillar collagen amplifies single cell traction forces. a) Pictographic representation of TFM procedure based on the displacement of fiducial 
markers. Right: original image with fluorescent beads of 100 nm size (red) and cell (green) and calculated force magnitude map. Scale bar 20 µm. 
b) Single cell strain energies of at least 60 cells from three independent experiments measured by TFM for seven primary donors. Each colored dot 
represents the calculated value of a single cells. c) Quantification of scaffold contraction (total volume) of seven primary donors cultured with ascorbic 
acid after two weeks of culture (mean ± S.D., n = 3–9). d) Quantification of fibrillar collagen signal density of scaffolds seeded with seven different 
primary donors after two weeks of culture (mean ± S.D., n = 3–7). e) SHI of scaffolds seeded with hdFs derived from donors 1 or 3 and cultivated for 14 d 
in the presence of ascorbic acid. Yellow arrowheads indicate cell-secreted collagen fibrils. Scale bar 100 µm. f) Calculated strain energy levels of total 
samples as a result of macroscopic contraction which were normalized to the total cell number. This results in values of strain energy per cell related 
to macroscopic contraction (mean ± S.D., n = 3–9). g) Calculated amplification factor for at least 60 cells reflecting the ratio between macroscopic 
strain energy per cell and the single cell force. h) Correlation of fibrillar collagen density and the median of calculated amplification factors indicating 
a positive linear correlation (r2 = 0.7).
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trauma, e.g., bone fracture. To gain insights into the mechan-
ical properties of this early healing environment, we performed 
mechanical compression tests on ten human bone fracture 
hematoma harvested either from proximal humerus or closed 
acetabulum fractures. We found a large inter-donor variability 
with a compressive stiffness ranging from E = 0.9 to 7.2 kPa 
and a mean of Emean = 2.9 ± 1.9 kPa (±S.D.) (Figure 4a). Visuali-
zation of collagen fibrils via histological Sirius Red staining and 
SHI revealed a cell- and ECM-rich tissue environment but only 
sporadically occurring collagen fibrils (Figure 4b).
To gain insights into the relevance of collagen fibrils for 
tissue contraction at different stages of healing, we aimed to 
study contraction in different mechanical environments fea-
turing the mechanical stiffness of the hematoma (<2 kPa), 
of intact soft tissues such as kidney or liver (4–5 kPa) and of 
maturing granulation tissue (25–50 kPa).[4,37] By adjusting 
the collagen solid content of the scaffolds, an additional soft 
scaffold (scaffold A, 1.1 wt%, Eaxial = 1.7 kPa) and an addi-
tional stiff scaffold (scaffold C, 3.0 wt%, Eaxial = 34 kPa) were 
produced next to the existing material (scaffold B, 1.5 wt%, 
Eaxial = 4.1 kPa) (Figure 4c). Scanning electron microscopy 
(SEM) revealed a similar pore architecture of the different pro-
totypes featuring aligned channel-like pores. Pore diameters 
were comparable between groups while the increase of wall 
thickness with increasing solid content was responsible for the 
increase in scaffold stiffness (Figure S4a–c, Supporting Infor-
mation). Although a higher density of wall-connecting struts 
was visible in the stiffer scaffold C, cell and collagen fiber align-
ment along the pores was comparable (Figure S4d, Supporting 
Information).
We analyzed scaffold contraction after 14 d of culture, both 
in the presence or absence of fibrillar collagen controlled by 
ascorbic acid supplementation. As differences in stiffness of 
the scaffold prototypes were higher in axial compared to radial 
direction, and as cells were predominantly orientated along 
the pores, the analysis of scaffold contraction was focused on the 
axial direction. As expected, the ability of the cells to contract the 
scaffold decreased with increasing scaffold stiffness (Figure 4d). 
In the absence of collagen fibrils, cells were only able to con-
tract scaffold A mimicking the soft hematoma environment. 
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Figure 4. Scaffold stiffness determines cellular strain output. a) Compressive stiffness of human fracture hematoma measured by monoaxial 
compression testing. Each colored dot represents the stiffness of 1 donor sample (10 in total). b) Histological sections of human fracture hematoma 
analyzed by Sirius red staining and SHI for visualization of collagen fibrils. Scale bar 200 µm in close-up views (1–4). c) Compressive stiffness of three 
different scaffolds (mean ± S.D., n = 3 each) produced from a collagen suspension of varying solid content (1.1–3.0 wt%). The compressive stiffness 
was measured both in axial (compression along the pores, blue) and radial (compression perpendicular to the pores, red) directions of the structured 
scaffolds. d) Quantification of scaffold axial contraction for hdFs cultured over 2 weeks inside the three prototypes (mean ± S.D., n = 3–9) either 
with or without the supplementation of ascorbic acid. Contraction is plotted over compressive stiffness (axial) of the scaffold prototypes A, B, and C. 
e) Quantification of fibrillar collagen density after culture of hdFs inside scaffold prototypes (mean ± S.D., n = 3–9) for 2 weeks either with or without 
the supplementation of ascorbic acid. Fibrillar collagen density is plotted over axial stiffness of the scaffold prototypes A, B, and C. Statistics via the 
Mann–Whitney U test (two-sided). Significance levels are indicated as: # p < 0.1., ** p < 0.01.
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Remarkably, in the presence of collagen fibrils not only scaffold 
A, but also scaffold B representing intact soft tissues was sig-
nificantly contracted. In stiff scaffolds C representing matured 
granulation tissue only a minor contraction was observed even 
in the presence of collagen fibrils. This suggested that only 
through the transfer of tension into the collagen fiber network, 
sufficient tension can be build up to mechanically contribute to 
tissue maturation from the hematoma phase toward the restora-
tion of the intact tissue’s mechanical properties. Tensional forces 
applied by the cells alone or with contributions from matrix 
components other than collagen-I (e.g., fibronectin) seem to 
be limited to very early stages of healing where the stiffness of 
the environment is low (E < 4 kPa). However, even in the pres-
ence of fibrillar collagen, tension-controlled contraction seems 
to reach a limit at a stiffness between 10 and 30 kPa in vitro. 
Interestingly, SHI showed that scaffold stiffness did not influ-
ence collagen fibril density (Figure 4e, Figure S4f, Supporting 
Information). This might indicate that the limited contraction 
of stiff scaffolds could be a consequence of a limited collagen 
fibril density under in vitro conditions. Here, the supply with 
nutrients and oxygen inside the scaffold is limited at long cul-
ture times—in contrast to a well-vascularized tissue in vivo.
Together, the use of scaffolds mimicking the mechanical 
environment at different stages of soft tissue healing revealed a 
fundamental role of collagen fibrils in the mechanical matura-
tion of tissues beyond the hematoma phase.
2.5. Collagen Fibrils Carry Mechanical Tension Independent  
of Active Cell Forces
Our data indicated that tissue contraction results from cell ten-
sional forces being incrementally transferred into a tensioned 
collagen fibril network. Consequently, tissue stability and ten-
sional state would be independent of active cell forces. In order 
to test if cell-secreted fibrillar collagen exhibited a load bearing 
capacity, we removed cellular components from the 3D scaf-
fold by detergent-based decellularization. The depletion was 
validated by histology and confocal microscopy (Actin, Nuclei) 
as well as residual DNA quantification after decellularization 
(Figure 5a, Figure S5a, Supporting Information). Immuno-
histology showed only a faint signal remaining for fibronectin 
while second harmonic generation (SHG) signal quantification 
demonstrated no negative effect of the decellularization proce-
dure on collagen density and only minor effects on collagen fiber 
alignment (Figure 5b, Figure S5b–d, Supporting Information). 
We further validated the protein composition of the decellular-
ized extracellular matrix (dECM) by liquid chromatography/
electron spray ionization mass spectrometry (LC/ESI–MS).[38] 
In total 21 different proteins were detected (Tables S1 and S2, 
Supporting Information) and collagens including type I, III, VI, 
and XII were identified resembling almost 80% of all detected 
peptides (Figure 5c,d). Residual cellular components such as 
histone and acto-myosin are regarded as debris from the decel-
lularization process which was further confirmed by western 
blotting to demonstrate the efficient removal of actin and his-
tone cellular components (Figure S5e, Supporting Information). 
Altogether, these data indicated that collagenous ECM was the 
main component retained after decellularization.
After 3 and 7 d of culture, no remaining contraction of 
the scaffold was visible upon decellularization indicating that 
collagen fibrils did not prevent the relaxation of the scaffold to 
its original shape (Figure 5e). Intriguingly, after 14 d of culture 
we detected a remaining contraction after decellularization rela-
tive to contraction observed with native samples both for radial 
(19%) and axial (57% remaining contraction) direction. When 
taking into account the different stiffness of the scaffold in 
axial and radial direction, a significantly higher strain energy 
was found to be stored in the axial direction of the scaffold 
(Figure 5f). As tensioned collagen fibrils seem to be necessary 
to hold the scaffold in a compressed state, the directionality 
of strain energy storage could be explained by the high align-
ment of collagen fibrils in the axial direction (Figure S5c–d, 
Supporting Information). Interestingly, the alignment of the 
collagen fibrils that results from the specific architecture of the 
scaffold pores is increased after decellularization (Figure S5c, 
day 3 and day 14, Supporting Information). This indicates 
that the collagen fibril network is straightened with removal 
of the cells, potentially as a consequence of eliminating radial 
components of cell tensional forces or because cell-occupied 
inter-fibril space was made available by decellularization. Fibril 
network straightening and resulting lengthening upon decellu-
larization might also explain the lack of remaining contraction 
after shorter time of culture (especially day 7) where scaffold 
strain in the axial direction was still low (mean contraction 
3.5%, Figure 2c). Mechanical characterization of scaffolds after 
decellularization verified that the scaffold stiffness was not 
altered over the time period of culture (Figure S5f, Supporting 
Information). This is of relevance for the interpretation of the 
scaffold contraction data but also for the calculation of the 
strain energy stored inside the collagen fibril network. To fur-
ther demonstrate that the contraction remaining after decel-
lularization was truly a result of collagen fibril tension rather 
than potential plastic deformation of the scaffold material, we 
treated decellularized scaffolds with collagenase in a concentra-
tion that completely degraded any cell-secreted ECM, but not 
the scaffold itself (Figure S5g, Supporting Information). Doing 
so, we observed a complete removal of remaining contraction 
and the release of the stored scaffold strain energy (Figure 5e,f). 
This demonstrates that the cell-secreted collagen fibril network 
in our in vitro model exhibited a load-bearing capacity that 
would be able to carry cell-traction forces upon transferred into 
the fibril network.
2.6. Collagen Fibrils—an Underestimated Regulator of Tissue 
Tension and Contraction?
Together our findings point to an incremental process in which 
cells contract and stabilize the environment by transferring 
tension to collagen fibrils. Such a “slip and ratchet” model for 
tissue contraction has been proposed and discussed for many 
years but the data presented here give a first in vitro evidence for 
the validity of this model (Figure 6).[3] Our findings suggest that 
collagen fibrils, beyond the current understanding of wound 
contraction, play an important role in re-establishing tension 
during tissue healing. The proposed amplification of cell forces 
that results from the storage of tensional force in extracellular 
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Figure 5. Fibrillar collagen stores cell-generated traction forces. a) Confocal images of hdFs seeded into scaffolds and cultured for 14 d either before 
(native) or after (decellularized) decellularization. Samples were stained for fibronectin (green), actin (red), and nuclei (blue). Scale bar 100 µm. 
b) Quantification of fibrillar collagen density inside scaffold pores after 3,7, or 14 d of culture before and after decellularization (mean ± S.D., n = 4–9). 
c) Functional enrichment analysis of detected proteins that were identified by mass spectrometry (GO:0005581, collagen trimer, red spheres). Lines 
illustrate interactions based on experiments, databases, coexpression, and co-occurrence in which the thickness depends on strength of data support. 
Minimum required interaction score: 0.7. d) EmPAI (exponentially modified protein abundance index) presented as heat map for three independent 
samples. e) Quantification of contraction after decellularization both for radial (red) and axial (blue) view (mean ± S.D., n = 3–18). f) Calculated strain 
energies derived from scaffold contraction both for radial and axial view (mean ± S.D., n = 3–18). Statistics via the Mann–Whitney U test (two-sided). 
Significance levels are indicated as: * p < 0.05., ** p < 0.01, ***p < 0.001.
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collagen fibrils is expected to generate tissue tension signifi-
cantly higher than the sum of cell traction forces alone.
However, it has to be pointed out that our interpretations 
are based on a 3D in vitro model system that comprises a 
number of limitations. Although we have demonstrated that 
the scaffold deforms elastically and maintains its properties 
throughout culture, we disregard microscopic variations (e.g., 
in wall thickness and pore diameter) that might affect cellular 
contractility and tensioning. This might be the case especially 
at early stages where a collective mechanosensation through 
long range fiber alignment is still missing. Furthermore, we 
do not take into account that cells and cell-secreted ECM might 
represent elements carrying compressive loads during tissue 
contraction that are not considered in the analysis. Such fac-
tors are difficult to assess but might influence the intrinsic 
tensional state of the tissue beyond the scope of this study. 
The actual magnitude of cellular force multiplication through 
collagen fibrils might thus differ significantly from our 
estimations.
During tissue regeneration, fibroblasts undergo a temporary 
and potentially reversible transition into myo-fibroblasts.[25,39] 
This is due to the presence of soluble factors such as TGF-β 
driving epithelial to mesenchymal transition (EMT), collagen 
I/III production and α-smooth muscle actin expression or an 
altered mechanical environment.[17,40–42] Myo-fibroblast acti-
vation was described as a function of tissue stiffness and the 
occurrence of myo-fibroblasts in vivo coincides with tissue 
stiffening and granulation tissue maturation.[4,39] We cannot 
exclude that fibroblasts were activated during scaffold-based in 
vitro culture, e.g., in response to the time-dependent increase 
of tissue stiffness. Donor-dependent fibroblast activation might 
thus contribute to the large inter-donor differences observed 
in macro scopic scaffold contraction (Figure 3c). As a further 
limitation of this study, such time-dependent alterations of cell 
traction forces in their physiological environment were disre-
garded. The quantification of traction forces via 2D TFM per-
formed here provides only limited information about the forces 
that cells exhibit in their physiological environment.[23] However, 
the only twofold increase in single cell forces upon fibroblasts 
activation by TGF-β compared to the large variation of scaf-
fold contraction (up to 17-fold) and of the amplification factor 
(up to 100-fold between D1 with AF D1, median = 0.23 and D3 with 
AF D3,median = 23) indicate that cell activation alone cannot explain 
the observed differences in the scaffold contraction behavior. 
Even under consideration of the above-mentioned limitations, 
the finding that scaffold contraction correlated linearly with col-
lagen fiber density but not with single cell force strongly points 
toward collagen fibrils as an essential regulator and potential 
storage of cell traction forces during scaffold/tissue contraction. 
Myo-fibroblast activation in vivo might further potentiate this 
effect since it not only increases cellular forces but also collagen 
secretion.[17,41]
From the proposed model, a direct connection results 
between the directionality of tissue tension and collagen fibril 
alignment. This suggests that regenerative approaches should 
aim at controlling collagen fibril deposition not only for struc-
tural optimization of the extracellular matrix but also to restore, 
or prevent, specific states of tissue pretension, e.g., in musculo-
skeletal tissues. First examples how patterned biomaterials can 
be used to avoid uncontrolled collagen formation and scarring 
to support tissue regeneration are emerging.[30]
Apart from the suggested relevance of collagen fibrils for 
wound contraction, aberrant collagen deposition and align-
ment is also a hallmark of tissue fibrosis and cancer.[43–50] 
Based on the finding that contraction and collagen fibril dep-
osition are mechanically linked rather than successive pro-
cesses, we speculate that an unbalanced collagen fibril-medi-
ated tissue contraction might contribute to the development 
of pathological situations. Consequently, aberrant collagen 
deposition during prefibrotic or premalignant stages might 
contribute in the path toward scar or tumor manifestation. 
Such an assumption is supported by in vitro, but also human 
mammogram studies, which could relate a collagen-rich tissue 
to an increased risk of developing breast cancer.[51,52] Although 
especially in malignant situations other factors (e.g., oncogene 
mutation, inflammatory response) are of highest relevance, 
altered collagen deposition rates would resemble a key link in 
transferring cellular alterations into a mechanical and struc-
tural constituent.
3. Conclusion
Together, we provide in vitro evidence that the storage of cell-
traction forces inside the cell-secreted collagen fibril network 
represents a relevant mechanical component in tissue ten-
sioning and contraction. A closer look at collagen fibrils as a 
key component in tissue tensioning might in future allow 
better control over pathological tissue alterations and motivate 
innovative approaches for successful tissue regeneration.
Adv. Sci. 2019, 6, 1801780
Figure 6. Fibrillar collagen amplifies single cell forces. Graphical illus-
tration of the here described tissue formation and tensioning process. 
Following initial cellular spreading and adhesion (1), cells incrementally 
deposit tensioned collagen fibrils (black arrows, 2) which leads to a 
gradual increase in the total force resulting in a macroscopic contraction 
(3). By this, the amount of macroscopic force exceeds the sum of single 
cell forces or contributions from nonfibrillar ECM networks. The collagen 
deposition rate thus determines the quantity of macroscopic contraction 
and tensioning of regenerating tissues, which is important to restore their 
function. Increased contraction, however, is associated with pathologies 
such as fibrosis and cancer.
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4. Experimental Section
Cell Isolation and Culture: Primary hdFs were isolated from human 
skin biopsy samples. Isolation of primary fibroblasts from patient-
derived material was approved by the Institutional Review Board of the 
Charité Berlin. All patients gave their written consent. Isolated cells were 
expanded in Dulbecco’s Modified Eagle Medium (DMEM, # 11960-044; 
Thermo Fischer) supplemented with fetal bovine serum (FBS, 10% 
(v/v), # S 0115; Biochrom AG), penicillin (100 U mL−1)and streptomycin 
(100 µg mL−1) (1% (v/v) # A 2213; Biochrom AG), and nonessential 
amino acids (NEA, 1% (v/v), # K 0293; Biochrom AG) at 37 °C with 5% 
CO2 in a humidified incubator. The hdFs were passaged when reaching 
confluence using 1 × Trypsin/EDTA (# 59418C; Sigma-Aldrich).
Scaffold Seeding and ECM Formation: All experiments were conducted 
using hdFs between passages 4 and 9. Optimaix macro-porous, 
porcine collagen I/III scaffolds were purchased from Matricel GmbH, 
Herzogenrath, Germany. Scaffolds were manufactured by a directional 
freezing and freeze-drying process with additional chemical cross-linking 
and used as a cell carrier.[28] Three scaffold types with solid collagen 
contents of 1.1, 1.5, or 3.0% (w/w) in the initial aqueous suspension 
were used in this study. Cylindrical scaffolds (Ø 5 mm, 3 mm height) 
were prepared from sheets using a biopsy punch. Scaffolds were seeded 
by dip-in-uptake from a concentrated cell suspension (7500 cells µL−1). 
The samples were incubated for 1 h at 37 °C in a humidified incubator 
w/o additional medium to allow cell adhesion, successively rinsed in 
expansion medium to remove unattached cells and placed into a well-
plate overnight. The next day, the samples were washed once and further 
incubated with DMEM tissue growth medium supplemented with 
FBS (2% (v/v)), P/S (1% (v/v)), NEA (1% (v/v)), and l-ascorbic acid 
(1.36 × 10−3 m) The medium was exchanged after 3, 7, and 10 d of culture.
Decellularization: Decellularization was performed in a Triton-X100 
(1% (v/v), #93443; Sigma-Aldrich)/SDS (0.1% (w/v), #15553027; 
Thermo Fischer) detergent solution at room temperature (RT) under 
continuous agitation for 48 h and with 1 solution exchange after 
24 h. The samples were washed in PBS and incubated with DNase I 
(700 U, # 10104159001; Roche) dissolved in PBS containing Calcium 
and Magnesium (# 14.040-091, Thermo Fischer) for further 24 h at 
RT. Finally, samples were washed in PBS w/o Calcium and Magnesium 
(# 14.190-094, Thermo Fischer).
DNA Quantification: DNA content was quantified using the CyQUANT 
Cell Proliferation Assay Kit (#C7026; Thermo Fischer) with an adopted 
protocol. In brief, samples were snap-frozen on dry ice and shattered 
in the cold under liquid nitrogen conditions using custom-made steel 
sticks and silicone pots and 1× Cell lysis buffer was added in the cold. 
The lysate was transferred to a test tube and centrifuged to pellet the 
scaffold debris. The supernatant was mixed in a 1:1 ratio with 2× GR 
working solution and the fluorescence was measured in a 96-well plate 
at 485/530 excitation/emission using a plate reader (Infinite 200pro, 
Tecan). For calculation of DNA amount/sample, a DNA standard curve 
was created according to the manufacturer’s instructions.
SEM: Scanning electron microscopy of freeze-dried, gold-sputtered 
samples was performed using the JCM-600 (JEOL GmbH) device.
Mechanical Testing: Elastic moduli of collagen scaffolds were 
analyzed by mono-axial compression testing of cubic samples using 
a BOSE ElectroForce Mechanical Test Instruments TestBench system 
equipped with a Model 31 Low load cell (Honeywell Corp.). Samples 
were compressed to 10% strain with a compression rate of 0.05 mm s−1 
and the position was kept constant for 30 seconds at 0 and 10% strain 
position respectively. Before the measurement, samples were scanned 
to obtain the cross-sectional area and height for the calculation of stress 
and strain values. Stress-strain curves were calculated and plotted from 
measured load and the Young’s Modulus E [Pa] was obtained from 
the linear region of the curve. Scaffold strain energy U for the different 
calculated for axial and radial scaffold orientation separately was 
calculated based on Equation (1)
1
2
U W F s= = ⋅ ⋅
 
(1)
Hematoma was harvested during orthopedic surgery 6 ± 3 d 
postfracture and mechanically tested within 1 h after surgery. Collection 
of human fracture hematoma was approved by the Institutional 
Review Board of the Charité Berlin. All patients gave their written 
consent. Hematoma samples were compressed over 15% strain with a 
compression rate of 1 mm min−1. Young’s Moduli were retrieved from 
the linear region of compression curves.
Bioreactor System: Permanent compressive loading with in situ 
monitoring of the mechanical properties was performed inside a 
custom-made bioreactor system described previously.[33] In brief, the 
system is composed of two separate compartments: a cell culture unit 
and a mechanical unit. The cell culture unit consists of a bioreactor 
chamber, a medium reservoir allowing gas exchange, and a micropump. 
It is combined with the mechanical unit allowing the application of 
defined loading patterns with online-force measurements. To mimic 
the scaffold contraction during tissue growth, empty collagen scaffolds 
(Ø = 8 mm) were incubated in full fibroblast expansion medium and 
compressed in incremental steps of 45 µm d−1 up to 10 d reaching a 
total compressive strain of 13%. To assess the change of mechanical 
properties over time, compression tests were conducted after each 
increment (= 24 h). Therefore, the upper plunger returned to its zero 
position (= initial position) and samples were compressed three times 
over 15% strain with a compression rate of 0.05 mm s−1. The position 
was kept constant for 30 s at 0 and 15% strain position, respectively.
Collagenase Degradation: Decellularized samples were enzymatically 
treated with crude collagenase I (# 17100-017, Thermo Fischer) as 
described previously.[53] In brief, crude collagenase I was dissolved in 
Tris-HCl (0.1 m, pH 7.4) supplemented with sodium azide (0.05 g L−1) 
and calcium chloride (5 × 10−3 m) and samples were treated with 1 U for 
24 h at 37 °C.
Western Blotting: Whole tissue samples were frozen and mechanically 
minced using custom-made steel pestle and silicone molds. Sample 
powder was mixed with a detergent buffer containing 4% CHAPS, 
50 × 10−3 m TRIZMA base, 50 × 10−3 m KCl, and 20% wt/vol glycerol 
at pH 7.5, as well as proteinase and phosphatase inhibitor cocktail 
(Complete, PhosStop; Roche). Lysates were sonicated on ice and 
successively mixed with a solution containing 6.5 m urea, 2 m thiourea, 
and 5 × 10−3 m magnesium chloride in a 2 + 1 ratio. The supernatant was 
used for electrophoresis by mixing 4× sample loading buffer (Li-Cor) and 
denaturation at 85 °C for 5 min. SDS-polyacrylamide gel electrophoresis 
and western blotting was performed using the NuPAGE electrophoresis 
system (Thermo Fischer) according to the manufacturer’s instructions. 
Proteins were transferred onto Protran nitrocellulose membrane 
(0.45 µm pore size, # GE10600003, Sigma-Aldrich) and blocked after 
transfer using Odyssey TBS blocking buffer (#927-50000, Li-Cor). Primary 
antibodies for histone H3 (#4499, Cell Signaling), β-actin (#8457, Cell 
Signaling) and collagen type I (#ab138492, abcam) were used according 
to the manufacturer’s instructions. Secondary antibodies (antirabbit, 
#925-32211, Li-Cor) were incubated using 3% BSA/TBS-T and signals 
were detected using the Odyssey infrared imaging system (Li Cor).
Mass Spectrometry: LC/ESI–MS was performed as described 
previously.[54] In brief, decellularized scaffolds were washed using 
Ammonium bicarbonate (25 × 10−3 m; Sigma-Aldrich)/Acetonitril Uvasol 
(2% (v/v); Merck) in water and twice with ammonium bicarbonate 
(25 × 10−3 m)/Acetonitril (50% (v/v)) in water at 37 °C. Afterward 
scaffolds were dehydrated with 100% acetonitrile at 37 °C. Samples 
were subjected to tryptic digestion at 37 °C over night (0.01 µg µL−1 
Trypsin in 50 × 10−3 m ammonium bicarbonate; Promega). Peptides were 
extracted with trifluoridic acid (0.1% (w/v)) and directly analyzed by LC/
ESI–MS. Peptides were separated (2–60% acetonitrile/ in 0.1% formic 
acid, flow rate 400 nL min−1) using an analytical UHPLC System (Dionex 
Ultimate 3000 RSLC, Thermo-Fisher, Waltham, MA USA) and analyzed 
via ESI-QTOF-mass spectrometer (Impact II, bruker daltonics, Billerica, 
MA, USA). Mass spectra were evaluated using MASCOT software 
(version number 2.2, Matrix Science, Boston, MA, USA) automatically 
searching the SwissProt 51.9 database (553 474 sequences; 198 069 095 
residues, Cambridgeshire, UK). MS/MS ion search was performed with 
the following set of parameters: i) taxonomy: homo sapiens (human) 
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(20 172 sequences); ii) proteolytic enzyme: trypsin; iii) maximum of 
accepted missed cleavages: 2; iv) mass value: monoisotopic; v) peptide 
mass tolerance 10 ppm; vi) fragment mass tolerance: 0.05 Da; and vii) 
variable modifications: oxidation of Methionine. Only proteins with 
scores corresponding to p < 0.05 and with at least two independent 
peptides which were identified, were considered. Visualization 
of protein interaction networks was performed using String DB 
(http://string-db.org) with high confidence interaction score (0.7) and 
experiments, databases, co-expression and co-occurrence as active 
interaction sources. GO enrichment analysis was performed using the 
open access platform Term Finder (http://go.princeton.edu/cgi-bin/
GOTermFinder) with cellular component as ontology aspect.
Scaffold Contraction Analysis: Scaffold contraction analysis was 
performed by scanning the samples at the respective time points 
in tissue growth medium using a digital scanner (1200 dpi, Epson 
perfection V200). The cross-sectional area (xy) was calculated by manual 
contouring of the sample in the top view and the height by measuring 
the average distance between top and bottom of the sample in the side 
view. The scaffold contraction was calculated as the percentile difference 
in area (top) or height (side) over the time of tissue growth normalized 
to the initial area/height (Equation 2).
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Immunofluorescent Staining and Imaging: Samples were fixed in 
paraformaldehyde solution (4% (w/v); Sigma-Aldrich) and the reaction 
was stopped with ammonium chloride (25 × 10−3 m (w/v)) buffered 
in PBS. Scaffolds were then incubated in gelatin (5% (w/v))/sucrose 
(5% (w/v)) buffered in PBS at 37 °C and successively transferred to 4 °C 
to allow solidification. The cylindrical samples were cut into halves and 
the gelatin was washed out with PBS at 37 °C. In order to obtain an even 
plane for imaging, the samples were finally processed by transferring 
them into cryomoulds, covering with Tissue-Tek* O.C.T. Compound 
(Sakura Inc., #25608-930) and snap-freezing under liquid nitrogen 
conditions. The surface was prepared in a CryoStat (LEICA CM3050S). 
The following antibodies and probes were used for immuno-fluorescent 
labelling: fibronectin (# ab23750; Abcam), α-smooth muscle actin 
(#M0851; Dako), α-rabbit IgG-A88 (#A-21206, Thermo Fischer), actin 
(Phalloidin-Alexa633, # A22284, Thermo Fischer, Phalloidin-Atto550, 
#19083, Sigma-Aldrich), DNA (DAPI, # 62247, Thermo Fischer; Draq5 
#424101, Biolegend). Microscopy was performed using a LEICA 
SP5 confocal microscope equipped with a Mai Tai HP multiphoton 
laser (Spectra Physics) and a 25-fold water immersion objective. 
620 µm × 620 µm × 52 µm volumes were recorded with a resolution 
of 0.6 µm × 0.6 µm × 4 µm voxel size. High-resolution images for 
quantification of scaffold wall thickness were recorded using a 63-fold 
water immersion objective with a resolution of 0.12 µm × 012 µm × 
0.98 µm voxel size. Fibrillar collagen was detected by second harmonic 
generation with laser power and detection parameters kept constant for 
all measured samples (SHG, 910 nm excitation, 440–460 nm detection).
Image Analysis: All analysis steps of confocal microscopy images were 
performed in ImageJ. Collagen scaffold pore diameter was quantified 
by manual measuring using confocal planes of SHG tile scans. The 
thickness of collagen walls was quantified using BoneJ.[55] For analysis 
of fibrillar collagen density, the scaffold pores were selected as a region 
of interest (ROI) and the sum of the signal intensity was normalized to 
the ROI volume. The orientation distribution of actin, fibronectin and 
newly formed fibrillar collagen inside the pores was quantified using 
OrientationJ.[56] The anisotropy was quantified inside scaffold pores 
using FibrilTool.[57] Cell numbers inside scaffolds were quantified based 
on cell density calculated from nuclei staining and successive particle 
counting using ImageJ. The amount of cells was converted into cell 
density and related to the total scaffold volume. Cell density heatmaps 
were generated by measuring cell density in a 200 µm grid pattern across 
whole sample cross-sections.
Histology: Cryosections of human fracture hematoma were prepared 
using a CryoStat (LEICA CM3050S). Sections were air-dried and 
stained with Sirius red solution (0.2% (w/v)) dissolved in saturated 
picric acid. Samples were further washed in acetic acid (0.5% (v/v)) 
followed by successive dehydration in 70–100% ethanol and xylol. 
Stained sections were imaged under a bright field microscope (Zeiss) at 
5× magnification.
Traction Force Microscopy: Quantification of single cell forces and 
calculation of force fields and strain energy values from recorded 
image pairs was performed as described previously.[34,35] In brief: Clean 
coverslips (22 × 40 mm, Langenbrinck GmbH #01-2240/1) were 
prepared by successive sonication in SDS (0.1% (w/v)), ddH2O, 70% 
ethanol and 100% for 30 min at 60 °C. Coverslips were activated using 
3-Aminopropyltrimethoxysilane (50% (v/v), APTMS, #281778; Sigma-
Aldrich) and glutaraldehyde (0.5% (v/v), #G5882; Sigma-Aldrich). 
Polyacrylamide (PAA) gels were prepared on activated coverslips 
using FluoSpheres (0.1 µm, #F8800; Thermo Fischer) embedded into 
acrylamide (#161-0140;Bio-Rad), bis-acrylamide (#161-0142; Bio-Rad). 
Polymerization was induced using ammonium persulfate solution (10% 
(w/v), # A3678; Sigma-Aldrich) and tetramethylethylendiamin (TEMED, 
#161-0800; Bio-Rad). Polyacrylamide gels were rinsed with ddH2O and 
coated using 50 µL fibronectin solution (1 mg mL−1, #341635; EMD 
Milipore) in combination with UV-light (10 mW cm−2 for 150 s) activated 
sulfosuccinimidyl 6-(4′-azido-2′-nitrophenylamino)hexanoate (Sulfo-
SANPAH, #22589; Thermo Fischer). The final elastic modulus of the PAA 
gels was validated by nanoindentation using the Piuma nanoindenter 
(Optics 11) with a 9 µm spherical cantilever tip. Coated substrates were 
washed with sterile PBS solution and seeded with hdFs at a density of 
3000 cells cm−2. For TGF-β or ascorbic acid prestimulation, cells were 
cultured 4 d prior to trypsinization either using 10 ng mL−1 TGF-β1 
(#100-21, Peprotech) or 50 × 10−6 m ascorbic acid. The next day, cells 
were stained with cell tracker green (CTG, Thermo Fischer, # C7025) 
and cover slips were transferred into a custom made perfusion chamber and 
mounted on top of an inverted confocal microscope (Leica SP5) equipped 
with a 63× water immersion objective. Images were recorded with a spatial 
resolution of 240 nm, and a z-resolution of 500 nm. Cells were removed by 
trypsinization and beads were recorded for marked cell positions to obtain 
image pairs. Calculations of strain energies per cell was based on Image-J 
plugins for Particle Image Velocimetry and Fourier Transform Traction 
Cytometry with regard of the cell outline based on CTG signals.[58]
Data Presentation and Statistics: All data are shown as mean value 
with standard deviation. Box plots are shown as box with 25% and 75% 
for lower and upper limits. The mean value is indicated as a square 
and the median as horizontal line. Diagonal crosses indicate outliers. 
Statistical analysis was performed using the OriginPro 2015G (OriginLab 
Corporation) software. Two-sided Mann–Whitney-U statistical test was 
used for assessing significance levels with a Bonferroni correction for 
comparison of multiple groups. A value of p < 0.05 was considered 
as statistically significant. Different significant levels are indicated as: 
# p < 0.1, * p < 0.05, ** p < 0.01, *** p < 0.001.
Supporting Information
Supporting Information is available from the Wiley Online Library or 
from the author.
Acknowledgements
The authors thank Simon Reinke (Core Unit “Cell Harvesting” of the 
Berlin-Brandenburg Centre for Regenerative Therapies) for providing 
skin biopsies and human fracture hematoma samples and acknowledge 
the support of Dag Wulsten (Julius Wolff Institute) during mechanical 
testing. The authors would further like to thank Hans Leemhuis 
(Matricel GmbH, Herzogenrath) for providing collagen scaffolds with 
different collagen contents for this study. This work was funded by 
the DFG research group FOR2165 “Regeneration in Aged Individuals” 
and the Einstein Centre for Regenerative Therapies. E.B. and S.S. are 
Adv. Sci. 2019, 6, 1801780
www.advancedsciencenews.com
1801780 (12 of 13) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
members of the DFG graduate school 203 “Berlin-Brandenburg School 
for Regenerative Therapies.”
Conflict of Interest
The authors declare no conflict of interest.
Keywords
cell force, collagen, extracellular matrix, second harmonic imaging, 
tension, tissue regeneration, traction force microscopy, wound 
contraction
Received: October 10, 2018
Revised: December 20, 2018
Published online: March 14, 2019
[1] R. Rudolph, World J. Surg. 1980, 4, 279.
[2] D. P. Berry, K. G. Harding, M. R. Stanton, B. Jasani, H. P. Ehrlich, 
Plast. Reconstr. Surg. 1998, 102, 124.
[3] J. J. Tomasek, G. Gabbiani, B. Hinz, C. Chaponnier, R. R. Brown, 
Nat. Rev. Mol. Cell Biol. 2002, 3, 349.
[4] B. Hinz, J. Biomech. 2010, 43, 146.
[5] T. Rozario, D. W. DeSimone, Dev. Biol. 2010, 341, 126.
[6] S. Calve, S. J. Odelberg, H. G. Simon, Dev. Biol. 2010, 344, 259.
[7] S. E. Mercer, S. J. Odelberg, H. G. Simon, Dev. Biol. 2013, 382, 457.
[8] K. E. Kubow, R. Vukmirovic, L. Zhe, E. Klotzsch, M. L. Smith, 
D. Gourdon, S. Luna, V. Vogel, Nat. Commun. 2015, 6, 8026.
[9] M. L. Smith, D. Gourdon, W. C. Little, K. E. Kubow, R. A. Eguiluz, 
S. Luna-Morris, V. Vogel, PLoS Biol. 2007, 5, 2243.
[10] W. R. Legant, A. Pathak, M. T. Yang, V. S. Deshpande, 
R. M. McMeeking, C. S. Chen, Proc. Natl. Acad. Sci. USA 2009, 106, 
10097.
[11] D. Könnig, A. Herrera, G. N. Duda, A. Petersen, J. Tissue Eng. 
Regener. Med. 2017, 4, 524.
[12] R. a. Pena, J. a. Jerdan, B. M. Glaser, Invest. Ophthalmol. Visual Sci. 
1994, 35, 2804.
[13] C. M. Bidan, P. Kollmannsberger, V. Gering, S. Ehrig, P. Joly, 
A. Petersen, V. Vogel, P. Fratzl, J. W. C. Dunlop, J. R. Soc., Interface 
2016, 13, 20160136.
[14] J. B. Forien, C. Fleck, P. Cloetens, G. Duda, P. Fratzl, E. Zolotoyabko, 
P. Zaslansky, Nano Lett. 2015, 15, 3729.
[15] L. Bertinetti, A. Masic, R. Schuetz, A. Barbetta, B. Seidt, 
W. Wagermaier, P. Fratzl, J. Mech. Behav. Biomed. Mater. 2015, 52, 14.
[16] D. C. Rockey, P. D. Bell, J. A. Hill, N. Engl. J. Med. 2015, 372, 1138.
[17] T. A. Wynn, J. Pathol. 2008, 214, 199.
[18] I. Acerbi, L. Cassereau, I. Dean, Q. Shi, a. Au, C. Park, Y. Y. Chen, 
J. Liphardt, E. S. Hwang, V. M. Weaver, Integr. Biol. 2015, 7, 1120.
[19] R. A. Brown, R. Prajapati, D. A. McGrouther, I. V. Yannas, 
M. Eastwood, J. Cell. Physiol. 1998, 175, 323.
[20] M. S. Sakar, J. Eyckmans, R. Pieters, D. Eberli, B. J. Nelson, 
C. S. Chen, Nat. Commun. 2016, 7, 11036.
[21] K. S. Midwood, L. V. Williams, J. E. Schwarzbauer, Int. J. Biochem. 
Cell Biol. 2004, 36, 1031.
[22] M. Marenzana, N. Wilson-Jones, V. Mudera, R. A. Brown, Exp. Cell 
Res. 2006, 312, 423.
[23] B. M. Baker, C. S. Chen, J. Cell Sci. 2012, 125, 3015.
[24] P. Joly, G. N. Duda, M. Schöne, P. B. Welzel, U. Freudenberg, 
C. Werner, A. Petersen, PLoS One 2013, 8, e73545.
[25] P. Kollmannsberger, C. M. Bidan, J. W. C. Dunlop, P. Fratzl, V. Vogel, 
Sci. Adv. 2018, 4, eaao4881.
[26] J. Knychala, N. Bouropoulos, C. J. Catt, O. L. Katsamenis, 
C. P. Please, B. G. Sengers, Ann. Biomed. Eng. 2013, 41, 917.
[27] M. Rumpler, A. Woesz, J. W. Dunlop, J. T. van Dongen, P. Fratzl, 
J. R. Soc., Interface 2008, 5, 1173.
[28] H. Schoof, J. Apel, I. Heschel, G. Rau, J. Biomed. Mater. Res. 2001, 
58, 352.
[29] J. Heino, V. Kähäri, S. Jaakkola, J. Peltonen, Matrix 1989, 9, 34.
[30] A. Petersen, A. Princ, G. Korus, A. Ellinghaus, H. Leemhuis, 
A. Herrera, A. Klaumünzer, S. Schreivogel, A. Woloszyk, 
K. Schmidt-Bleek, S. Geissler, I. Heschel, G. N. Duda, Nat. 
Commun. 2018, 9, 4430.
[31] L. Quintana, T. F. Muiños, E. Genove, M. Del Mar Olmos, 
S. Borrós, C. E. Semino, Tissue Eng., Part A 2009, 15, 45.
[32] F. Grinnell, J. Cell Biol. 1994, 124, 401.
[33] A. Petersen, P. Joly, C. Bergmann, G. Korus, G. N. Duda, Tissue 
Eng., Part A 2012, 18, 1804.
[34] S. Plotnikov, B. Sabass, U. Schwarz, C. M. Waterman, Methods Cell 
Biol. 2014, 123, 367.
[35] J. L. Martiel, A. Leal, L. Kurzawa, M. Balland, I. Wang, T. Vignaud, 
Q. Tseng, M. Théry, Methods Cell Biol. 2015, 125, 269.
[36] A. Marinkovic, J. D. Mih, J.-A. Park, F. Liu, D. J. Tschumperlin, Am. 
J. Physiol.: Lung Cell. Mol. Physiol. 2012, 303, L169.
[37] A. M. Handorf, Y. Zhou, M. A. Halanski, W. J. Li, Organogenesis 
2015, 11, 1.
[38] B. Kappler, P. Anic, M. Becker, A. Bader, K. Klose, O. Klein, 
B. Oberwallner, Y. H. Choi, V. Falk, C. Stamm, J. Mater. Sci.: Mater. 
Med. 2016, 27, 1.
[39] I. Darby, O. Skalli, G. Gabbiani, Lab. Invest. 1990, 63, 21.
[40] B. Hinz, J. Invest. Dermatol. 2007, 127, 526.
[41] P. D. Arora, N. Narani, C. A. McCulloch, Am. J. Pathol. 1999, 
154, 871.
[42] B. Hinz, G. Celetta, J. J. Tomasek, G. Gabbiani, C. Chaponnier, Mol. 
Biol. Cell 2001, 12, 2730.
[43] M. Perepelyuk, L. Chin, X. Cao, A. Van Oosten, V. B. Shenoy, 
P. A. Janmey, R. G. Wells, PLoS One 2016, 11, e0146588.
[44] D. T. Corr, D. A. Hart, Adv. Wound Care 2013, 2, 37.
[45] E. Melo, N. Cárdenes, E. Garreta, T. Luque, M. Rojas, 
D. Navajas, R. Farré, J. Mech. Behav. Biomed. Mater. 2014, 37, 
186.
[46] R. Bataller, D. Brenner, J. Clin. Invest. 2005, 115, 209.
[47] P. D. Verhaegen, H. J. Schouten, W. Tigchelaar-Gutter, J. Van Marle, 
C. J. Van Noorden, E. Middelkoop, P. P. Van Zuijlen, Wound Repair 
Regener. 2012, 20, 658.
[48] K. Zhang, M. D. Rekhter, D. Gordon, S. H. Phan, Am. J. Pathol. 
1994, 145, 114.
[49] T. T. Vellinga, S. Den Uil, I. H. B. Rinkes, D. Marvin, B. Ponsioen, 
A. Alvarez-Varela, S. Fatrai, C. Scheele, D. A. Zwijnenburg, 
H. Snippert, L. Vermeulen, J. P. Medema, H. B. Stockmann, 
J. Koster, R. J. A. Fijneman, J. De Rooij, O. Kranenburg, Oncogene 
2016, 35, 5263.
[50] M. W. Conklin, J. C. Eickhoff, K. M. Riching, C. A. Pehlke, 
K. W. Eliceiri, P. P. Provenzano, A. Friedl, P. J. Keely, Am. J. Pathol. 
2011, 178, 1221.
[51] S. Alowami, S. Troup, S. Al-Haddad, I. Kirkpatrick, P. H. Watson, 
Breast Cancer Res. 2003, 5, R129.
[52] B. R. Seo, P. Bhardwaj, S. Choi, J. Gonzalez, R. C. A. Eguiluz, 
K. Wang, S. Mohanan, P. G. Morris, B. Du, X. K. Zhou, L. T. Vahdat, 
A. Verma, O. Elemento, C. A. Hudis, R. M. Williams, D. Gourdon, 
A. J. Dannenberg, C. Fischbach, Sci. Transl. Med. 2015, 7, 301ra130.
[53] M. L. Jarman-Smith, T. Bodamyali, C. Stevens, J. A. Howell, 
M. Horrocks, J. B. Chaudhuri, J. Mater. Sci.: Mater. Med. 2004, 
15, 925.
[54] M. Becker, J. A. Maring, M. Schneider, A. X. Herrera Martin, 
M. Seifert, O. Klein, T. Braun, V. Falk, C. Stamm, Int. J. Mol. Sci. 
2018, 19, 1032.
Adv. Sci. 2019, 6, 1801780
www.advancedsciencenews.com
1801780 (13 of 13) © 2019 The Authors. Published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
www.advancedscience.com
[55] M. Doube, M. M. Klosowski, I. Arganda-Carreras, F. P. Cordelières, 
R. P. Dougherty, J. S. Jackson, B. Schmid, J. R. Hutchinson, 
S. J. Shefelbine, Bone 2010, 47, 1076.
[56] R. Rezakhaniha, A. Agianniotis, J. T. C. Schrauwen, A. Griffa, 
D. Sage, C. V. C. Bouten, F. N. Van De Vosse, M. Unser, 
N. Stergiopulos, Biomech. Model. Mechanobiol 2012, 11, 461.
[57] A. Boudaoud, A. Burian, D. Borowska-Wykręt, M. Uyttewaal, 
R. Wrzalik, D. Kwiatkowska, O. Hamant, Nat. Protoc. 2014, 9, 
457.
[58] Q. Tseng, E. Duchemin-Pelletier, A. Deshiere, M. Balland, 
H. Guillou, O. Filhol, M. Thery, Proc. Natl. Acad. Sci. USA 2012, 
109, 1506.
Adv. Sci. 2019, 6, 1801780
